Clinical Trials Sponsored by Baxter Healthcare Corporation

Total 499 results

Baxter Healthcare Corporation

Recruiting

Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT

Regional Citrate Anticoagulation (RCA) | Continuous Renal Replacement Therapy (CRRT) | Acute Kidney Injury (AKI)

United States
Baxter Healthcare Corporation

Completed

Starling Registry Study

Hemodynamic Monitoring

United States
Baxter Healthcare Corporation

Enrolling by invitation

Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018

Febrile Illness

United States
Baxter Healthcare Corporation

Completed

Post-Market Study of Low-flow ECCO2R Using PrismaLung+

Mild to Moderate Acute Respiratory Distress Syndrome

France
Baxter Healthcare Corporation

Withdrawn

Starling/CRRT Observational Study

Hemodynamic Monitoring

United States
Baxter Healthcare Corporation

Completed

Cefazolin PK Study 3g vs 2g

Healthy

United States
Baxter Healthcare Corporation

Completed

Clinical Performance Comparison of 2 THERANOVA 400 Dialyzer Prototypes in HD With High-Flux Dialyzers in HD and hv HDF Mode

End Stage Renal Disease

Germany
Baxter Healthcare Corporation

Completed

Exploratory Study to Explore the Safety and Efficacy of the HDx Therapy Using Theranova 500 Dialyzer in Comparison to Hemodiafiltration

End Stage Renal Disease

Spain
Baxter Healthcare Corporation

Terminated

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion

Essential Fatty Acid Deficiency (EFAD)

United States
Baxter Healthcare Corporation

Terminated

Prismaflex HF20 Set and Prismaflex® System 7.10/7.20 for Acute Continuous Renal Replacement Therapy (CRRT) in Children

Acute Kidney Injury in Pediatric Patients

United States
Baxter Healthcare Corporation

Terminated

Healthy Volunteer Study to Evaluate the Impact of Various Common Interventions on Venous Pressure Signal Captured by PIVA

Healthy Volunteers

United States
Baxter Healthcare Corporation

Completed

Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients

End Stage Renal Disease

United States
Baxter Healthcare Corporation

Completed

Observational Study Using the CoVa Monitoring System 3

Healthy

United States
Baxter Healthcare Corporation

Completed

Clinical Observation of the Performance of Artis Dialysis System, ArtiSet PrePost and Ultra HDF Line in Treatments of Patients With End-Stage Renal Disease (ESRD)

End-Stage Renal Disease

China
Baxter Healthcare Corporation

Completed

Efficacy and Safety of TISSEEL Lyo Compared to Manual Compression as an Adjunct to Haemostasis

Adjunct to Hemostasis During Vascular Surgery

Russian Federation
Baxter Healthcare Corporation

Completed

Japan Phase 2/3 Clinical Study With BLM-240 (Desflurane)

Anesthesia

Japan
Baxter Healthcare Corporation

Completed

Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China

End Stage Renal Disease

China
Baxter Healthcare Corporation

Terminated

Heart Failure and Peritoneal Ultrafiltration

Congestive Heart Failure

United States, Belgium, Canada, Australia
Baxter Healthcare Corporation

Completed

Automated Setting of Individualized Sodium Technology (ASIST)

End Stage Renal Disease (ESRD)

Sweden
Baxter Healthcare Corporation

Terminated

Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in China

End Stage Renal Disease

China
Baxter Healthcare Corporation

Completed

Monitoring Subjects With Fluid-Management Issues In the Home Environment

Heart Failure | Hypertension

United States
Baxter Healthcare Corporation

Completed

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

Influenza

United States
Baxter Healthcare Corporation

Completed

Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation

Nutrition Support

China
Baxter Healthcare Corporation

Completed

Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-containing Solutions in Post-Surgical Dental Pain

Pain, Postoperative

United Kingdom
Baxter Healthcare Corporation

Completed

Comparison of the Impact of Dialysis Treatment Type on Patient Survival

End Stage Renal Disease

China
Baxter Healthcare Corporation

Completed

A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis

End Stage Renal Disease

Canada
Baxter Healthcare Corporation

Completed

Performance and Safety of Bone Substitute MBCP-FS in Maxillary Sinus Lift Procedures

Sinus Implant Reconstruction

Germany
Baxter Healthcare Corporation

Completed

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement

Hip Replacement Surgery

Austria, Germany, Netherlands
Baxter Healthcare Corporation

Completed

Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds

Burns

United States
Baxter Healthcare Corporation

Recruiting

Theranova Randomized, Controlled, Trial (RCT) in China

Acute Kidney Failure | Chronic Kidney Failure

China
Baxter Healthcare Corporation

Active, not recruiting

PMCF Study for COSEAL® in Gynecologic Surgery

Adhesion

United States, Italy
Baxter Healthcare Corporation

Enrolling by invitation

A Post-Market Clinical Performance and Safety Evaluation of GamCath HighFlow Dolphin Protect Catheter

ESRD | Acute Renal Failure | CKD | AKI - Acute Kidney Injury

Poland
Baxter Healthcare Corporation

Completed

Hemopatch Performance Evaluation: A Prospective Observational Registry

Air Leakage | Dura Mater Nick Cut or Tear | Hemostatis | Body Fluid Leakage

Germany, Spain, Czechia, Italy, Austria
Baxter Healthcare Corporation

Terminated

Performance Evaluation of the AMIA APD Solution Generation System in Patients End Stage Renal Disease (ESRD)

End Stage Renal Disease (ESRD)

United States
Baxter Healthcare Corporation

Terminated

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

Acute Kidney Injury | Regional Citrate Anticoagulation (RCA) | Continuous Renal Replacement Therapy (CRRT)

United States, Canada
Baxter Healthcare Corporation

Completed

Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding (CELSTAT)

Bleeding Active

United States, Czechia, Germany, Poland
Baxter Healthcare Corporation

Completed

Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer

End Stage Renal Disease

China
Baxter Healthcare Corporation

Completed

Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration

End Stage Renal Disease

China
Baxter Healthcare Corporation

Completed

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients (Impendia)

Diabetes | ESRD | CAPD | APD

Taiwan, Korea, Republic of, Singapore, Hong Kong, Russian Federation
Baxter Healthcare Corporation

Completed

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients (Impendia)

Diabetes | ESRD

Australia, Canada, New Zealand
Baxter Healthcare Corporation

Terminated

Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis

Gastroenteritis | Dehydration

United States, Canada
Baxter Healthcare Corporation

Completed

Efficacy and Safety Study of Anti-Adhesion Product in the Prevention of Intraperitoneal Adhesions

Intraperitoneal Adhesions

Denmark, Poland, Sweden
Baxter Healthcare Corporation

Completed

Necklace-Shaped Sensor for Non-Invasive Monitoring of Stroke Volume and Cardiac Output

Heart Failure
Baxter Healthcare Corporation

Completed

Effects of IV Chloride Content on Outcomes

SIRS | Balanced Fluids | Plasmalyte

United States
Baxter Healthcare Corporation

Withdrawn

Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients

Peritoneal Dialysis | Hypertriglyceridemia

United States
Baxter Healthcare Corporation

Completed

Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients

Deep Partial or Full Thickness Wounds

United States
Baxter Healthcare Corporation

Completed

Neck-Worn Monitoring Sensor for - A Study for Monitoring Subjects With Fluid-Management Issues During Dialysis

Heart Failure | Kidney Disease

United States
Baxter Healthcare Corporation

Completed

Fibrin Sealant for the Sealing of Dura Sutures

Dura Defects | Pathological Processes in the Posterior Fossa

United States, Canada
Baxter Healthcare Corporation

Completed

e-STEPS: Endotoxin-Associated Sterile Peritonitis Observational Study (e-STEPS)

Endotoxin-associated Sterile Peritonitis

United Kingdom, Germany, Hungary, Netherlands, Portugal
Baxter Healthcare Corporation

Completed

Efficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS VH S/D 4) in Face-Lift Procedures

Facial Rhytidectomy (Face-lift)

United States

Clinical Trials Sponsored by Baxter Healthcare Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations